These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 19926734
1. Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Chee CB, KhinMar KW, Gan SH, Barkham TM, Koh CK, Shen L, Wang YT. Eur Respir J; 2010 Aug; 36(2):355-61. PubMed ID: 19926734 [Abstract] [Full Text] [Related]
4. Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levels. Komiya K, Ariga H, Nagai H, Kurashima A, Shoji S, Ishii H, Nakajima Y. J Infect; 2011 Jul; 63(1):48-53. PubMed ID: 21624664 [Abstract] [Full Text] [Related]
5. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Int J Tuberc Lung Dis; 2008 Jan; 12(1):50-6. PubMed ID: 18173877 [Abstract] [Full Text] [Related]
7. Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis. Kik SV, Franken WP, Arend SM, Mensen M, Cobelens FG, Kamphorst M, van Dissel JT, Borgdorff MW, Verver S. Int J Tuberc Lung Dis; 2009 Jul; 13(7):820-8. PubMed ID: 19555530 [Abstract] [Full Text] [Related]
8. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Lucas M, Nicol P, McKinnon E, Whidborne R, Lucas A, Thambiran A, Burgner D, Waring J, French M. Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869 [Abstract] [Full Text] [Related]
15. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey. Sato R, Nagai H, Matsui H, Kawabe Y, Takeda K, Kawashima M, Suzuki J, Ohshima N, Masuda K, Yamane A, Tamura A, Akagawa S, Ohta K. J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204 [Abstract] [Full Text] [Related]
16. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Lee SH, Lew WJ, Kim HJ, Lee HK, Lee YM, Cho CH, Lee EJ, Lee DY, Ryu SW, Oh SY, Kim SO, Shim TS. Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123 [Abstract] [Full Text] [Related]
17. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M. J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944 [Abstract] [Full Text] [Related]
18. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection. Chen YM, Chen HH, Lai KL, Hung WT, Lan JL, Chen DY. Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552 [Abstract] [Full Text] [Related]
19. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM. Eur Respir J; 2007 Jun; 29(6):1212-6. PubMed ID: 17215314 [Abstract] [Full Text] [Related]